Bafna Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bafna Pharmaceuticals Ltd. on BSE

Search Inside the pdf :

Bafna Pharmaceuticals Ltd.

19 Sep 2025, 06:38PM

138.19

5.00%

Company Update

Bafna Pharmaceuticals Ltd - 532989 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

We hereby inform that the Members at the 30th Annual General Meeting of the Company held on September 19, 2025 had inter-alia approved (i) Appointment of Mr. Navin Kumar as Independent Director of the Company and (ii) Re-appointment of Mr. Palamadai Krishnan Sundaresan and Mrs. Ravichandran Chitra as Independent Directors of the Company.

pdf

Bafna Pharmaceuticals Ltd.

19 Sep 2025, 06:33PM

138.19

5.00%

Company Update

Bafna Pharmaceuticals Ltd - 532989 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

pdf

Bafna Pharmaceuticals Ltd.

19 Sep 2025, 03:56PM

138.19

5.00%

AGM

Bafna Pharmaceuticals Ltd - 532989 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

We herewith enclose the Outcome / Proceedings of the 30th Annual General Meeting of the Company held on September 19, 2025.

pdf

Bafna Pharmaceuticals Ltd.

28 Aug 2025

138.19

5.00%

Company Update

Bafna Pharmaceuticals Ltd - 532989 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

We herewith enclose the Newspaper Publication in connection with 30th Annual General Meeting of the Company.

pdf

Bafna Pharmaceuticals Ltd.

26 Aug 2025

138.19

5.00%

AGM

Bafna Pharmaceuticals Ltd - 532989 - Notice Of 30Th Annual General Meeting Of The Company For …

BSE India

We herewith enclose the Notice of 30th Annual General Meeting of the Company scheduled to be held on Friday, September 19, 2025 at 10.00 A.M, for the FY 2024-2025.

pdf

Bafna Pharmaceuticals Ltd.

26 Aug 2025

138.19

5.00%

Corp. Note

Bafna Pharmaceuticals Ltd - 532989 - Reg. 34 (1) Annual Report.

BSE India

We herewith enclose the Annual Report of the Company for the F.Y 2024-2025.

pdf

Bafna Pharmaceuticals Ltd.

21 Aug 2025

138.19

5.00%

Corp. Action

Bafna Pharmaceuticals Ltd - 532989 - Book Closure For 30Th Annual General Meeting (AGM)

BSE India

Intimation for Book Closure for the purpose of 30th Annual General Meeting of the Company.

pdf

Bafna Pharmaceuticals Ltd.

21 Aug 2025

138.19

5.00%

AGM

Bafna Pharmaceuticals Ltd - 532989 - Shareholder Meeting - 30Th AGM On September 19, 2025

BSE India

We hereby inform that the 30th Annual General Meeting of the Company (AGM) is scheduled to be held on Friday, September 19, 2025 at 10.00 A.M through Video Conferencing (VC) / Other Audio Visual Means (OAVM).

pdf

Bafna Pharmaceuticals Ltd.

14 Aug 2025

138.19

5.00%

Company Update

Bafna Pharmaceuticals Ltd - 532989 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

We hereby enclose the Newspaper Publication of the Extract of the Unaudited Financial Results of the Company for the Quarter ende June 30, 2025 in "Business Standard" and "Makkal Kural" on August 14, 2025.

pdf

Bafna Pharmaceuticals Ltd.

12 Aug 2025

138.19

5.00%

Company Update

Bafna Pharmaceuticals Ltd - 532989 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

We hereby inform that the Board of Directors at its Meeting held on 12/08/2025 has approved the re-appointment of Mrs. Ravichandran Chitra (DIN: 07749125) and Mr. Palamadai Krishnan Sundaresan (DIN: 06954189) as Non-Executive Independent Directors of the Company for a Second Term of Five consecutive years, subject to approval of Shareholders at the ensuing Annual General Meeting.

pdf

Is Bafna Pharmaceuticals Ltd. worth buying?

24 Votes:

Buy 66.67%

Sell 25.0%

Hold 8.33%

New 52W High today

High volume+gain today

Bafna Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bafna Pharmaceuticals Ltd. on BSE